Перегляд зібрання за групою - Автори Gurianov, V.

Перейти до: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
А Б В Г Д Е Ж З И Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Ъ Ы Ь Э Ю Я І Ї Є
або ж введіть декілька перших літер:  
Результати 12 до 23 із 23 < назад 
Дата випускуНазваАвтор(и)
2022Lack of Difference in Tocilizumab Efficacy in the Treatment of Severe COVID-19 Caused by Different SARS-CoV-2 VariantsOliynyk, O.; Barg, W.; Oliynyk, Y.; Dubrov, S.; Gurianov, V.; Rorat, M.
2022Lack of Difference in Tocilizumab Efficacy in the Treatment of Severe COVID-19 Caused by Different SARS-CoV-2 VariantsOliynyk, O.; Barg, W.; Oliynyk, Y.; Dubrov, S.; Gurianov, V.; Rorat, M.
2022Metabolic and Anthropometric Parameters of Persons at Risk of Developing Type 2 Diabetes Mellitus Before and After 3 Months of Consuming Insoluble Dietary FiberKhalangot, M.; Gurianov, V.; Zakharchenko, T.; Pysarenko, Y.; Kravchenko, V.
2022National assessment of pneumonia morbidity in children in the period 1993-2017 and prognosis for 2025Vezhnovets, E.; Yashchenko, Y.; Gurianov, V.
2022Prediction of mortality in severely injured patients with facial bone fracturesShumynskyi, I.; Gurianov, V.; Kaniura, O.; Kopchak, A.
2022Prediction of mortality in severely injured patients with facial bone fracturesShumynskyi, I.; Gurianov, V.; Kaniura, O.; Kopchak, A.
2021Predictors Of Independent Walking Recovery After Stroke In Patients Admitted To An Integrated Stroke UnitFlomin, Y.; Gurianov, V.; Guliaieva, M.; Kushnerenko, O.; Gavryliv, I.; Sokolova, L.
2019Prognostic model of skin cancer risk assessmentOshyvalova, O.; Ziukov, O.; Gurianov, V.
2023-01RAAS inhibitors are associated with a better chance of surviving of inpatients with Covid-19 without a diagnosis of diabetes mellitus, compared with similar patients who did not require antihypertensive therapy or were treated with other antihypertensivesKhalangot, M.; Sheichenko, N.; Gurianov, V.; Zakharchenko, T.; Kravchenko, V.; Tronko, M.
2022Relationship between hyperglycemia, waist circumference, and the course of COVID-19: Mortality risk assessmentKhalangot, M.; Sheichenko, N.; Gurianov, V.; Vlasenko, V.; Kurinna, Y.; Samson, O.; Tronko, M.
2022-06Response to neoadjuvant chemotherapy in breast cancer: do microRNAs matter?Ryspayeva, D.; Halytskiy, V.; Kobyliak, N.; Dosenko, I.; Fedosov, A.; Inomistova, M.; Drevytska, T.; Gurianov, V.; Sulaieva, O.
2022The trends of the density of surgeons in some European countries and 16 OECD countries during 2005-2018Vezhnovets, T.; Paryi, V.; Gurianov, V.; Korotkyi, O.